Further to its communication dated 2nd February 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ajanta Pharma has informed that written transcript of the earnings call held on 1st February 2023 at 4.00 pm has been uploaded on the Company’s website and can be accessed through the link: https://ajantapharma.com//images/EarningsCallTranscriptQ3(Oct-Dec)2022-23.pdf.
The above information is a part of company’s filings submitted to BSE.
